AnewPharma: Clinical Trials

4 trials sponsored by AnewPharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Unknown 4

Follow AnewPharma: new trials by email

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CM082 and JS001 in Patients With Advanced Small-cell Lung Cancer (SCLC)
CM082 plus JS001 - Small Cell Lung Cancer
Phase 2UnknownAnewPharma302019-09-182020-07-09
CM082 and JS001 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC).
CM082 plus JS001 - Non-small Cell Lung Cancer
Phase 2UnknownAnewPharma202019-04-022020-07-09
Safety and Tolerability of Oral CM082 in Patients With wAMD
CM082 - Age-Related Macular Degeneration
Phase 2UnknownAnewPharma642018-11-222020-01-13
Study of the Combination of CM082 With JS001 in Patients With Advanced Mucosal Melanoma.
CM082 plus JS001 - Mucosal Melanoma
Phase 2UnknownAnewPharma402018-07-312019-07-05

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Macular Degeneration (1)  ·  Small Cell Lung Carcinoma (1)

Interventions

vorolanib (4)  ·  toripalimab (2)

Countries

China (4)

Top investigators

Jun Guo, M.D (1)  ·  Yin Shen (1)  ·  Yuankai Shi, MD (1)  ·  Zhao Jun, M.D (1)